Lubrizol to Sell Active Pharma, Intermediates Units
March 31, 2006 | By: Rachel Chapman
The Lubrizol Corporation announced plans to sell its active pharmaceutical ingredient and intermediate compounds business facilities in Raubling, Germany, and Chennai, India (A&I), respectively, to Auctus Management GmbH (Auctus) and the current management of the active pharmaceutical ingredient business. This reportedly is Lubrizol’s fifth and last planned divestiture since it announced its intent in July to market non-core businesses with combined revenues of US$500 million. Terms of the sale were not disclosed.
Z-COTE LSA provides broad-spectrum protection from long wave UVA rays and medium wave UVB rays by physically scattering, reflecting and absorbing solar radiation.
- Zinc Oxide
- UVA, UVB Sunscreen
- UVA Protection
- UVB Protection